Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1380 of 5804
-
Supercharged immune cells take on Hard-to-Treat myeloma
Disease control CompletedThis phase I trial tests the side effects and best dose of TGFbi natural killer (NK) cells (TiNK) when given together with isatuximab for the treatment of patients with multiple myeloma that has come back after a period of improvement (relapsed) or that has not responded to treat…
Phase: PHASE1 • Sponsor: Elvira Umyarova • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Could a simple drug make brain aneurysm surgery safer?
Disease control CompletedTo explore whether administering tirofiban in stent-assisted coiling/flow diverting treatments for participants with unruptured intracranial aneurysms can reduce new ischemic lesions on postoperative DWI sequences compared to conventional dual antiplatelet therapy.
Phase: PHASE2, PHASE3 • Sponsor: Beijing Tiantan Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Targeted pill takes on rare skull base cancers
Disease control Recruiting nowBackground: Cancers of the nasal cavity or skull base are rare. They often are not diagnosed until they are at an advanced stage, and they often spread to other parts of the body. These cancers may have mutations in a gene called IDH2. Researchers want to find out if a drug (ena…
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New antibody combo takes aim at Hard-to-Treat lymphoma
Disease control OngoingThis is the first-in-human study with BYON4228, a humanized monoclonal antibody (mAb) directed against SIRPα.
Phase: PHASE1 • Sponsor: Byondis B.V. • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
New hope for muscle disease: experimental drug ARO-DM1 enters human trials
Disease control Recruiting nowThis is a phase 1/2a double-blinded, placebo-controlled, dose-escalating study to evaluate the safety, tolerability, pharmacokinetics (PK) and pharmacodynamics (PD) of single and multiple ascending doses of ARO-DM1 compared to placebo in male and female subjects with type 1 myoto…
Phase: PHASE1, PHASE2 • Sponsor: Arrowhead Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
New cocktail targets Hard-to-Treat myeloma
Disease control Recruiting nowThis phase I trial tests the safety, side effects, and best dose of venetoclax in combination with lenalidomide and dexamethasone, daratumumab and dexamethasone, or daratumumab, lenalidomide, and dexamethasone in treating patients with multiple myeloma. Venetoclax is in a class o…
Phase: PHASE1 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Stem cells may supercharge CAR t for tough blood cancers
Disease control Recruiting nowThe study is designed to examine the feasibility and safety of collecting autologous hematopoietic stem cells (HSCs) to be combined with CAR T-cell therapy for patients with relapsed/refractory (r/r) hematological disease. The study will evaluate feasibility of collecting the tar…
Phase: PHASE1 • Sponsor: Joshua Sasine, MD, PhD • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Robot training aims to get stroke patients back on their feet faster
Symptom relief Recruiting nowThe ERA Stroke project will compare the effects of robotic gait training (RGT) and usual care (UC) gait training in patients in the subacute phase of stroke recovery undergoing inpatient rehabilitation at the Baylor Scott \& White Institute for Rehabilitation (BSWIR).
Phase: NA • Sponsor: Baylor Research Institute • Aim: Symptom relief
Last updated Jun 27, 2026 09:02 UTC
-
New drug litfulo tracked in Real-World hair loss study
Disease control OngoingThe objective of this Study is to confirm the safety during the long-term use of this drug and the effectiveness during the use of this drug under the actual use in the patients treated with this drug.
Sponsor: Pfizer • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Job interview training for autistic youth shows promise
Symptom relief ENROLLING_BY_INVITATIONThe purpose of the study is to see if an internet job interview training program can help people that have autism improve interview skills and access to jobs. Participants will be randomized to use Virtual Interview Training (VIT) or continue services as usual (active control gr…
Phase: NA • Sponsor: University of Michigan • Aim: Symptom relief
Last updated Jun 27, 2026 09:11 UTC
-
Diet and fasting combo shows promise for Alzheimer's patients
Disease control CompletedThis study investigates the effects of the Ketoflex 12/3 diet on the clinical progression of early-to-mid stage Alzheimer's disease. The study evaluates cognitive function, metabolic changes, and overall health outcomes in participants following the Ketoflex 12/3 dietary protocol…
Phase: NA • Sponsor: Prof. Lutfu Hanoglu, MD • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Dream control therapy eases night terrors and sleep paralysis in narcolepsy patients
Symptom relief CompletedThis randomized controlled trial evaluated the efficacy of a cognitive behavioral intervention based on lucid dreaming training and imagery control therapy for reducing REM-related symptoms in patients with narcolepsy type 1. Specifically, the study examined the impact of the int…
Phase: NA • Sponsor: Institute of Behavioral Sleep Medicine, Colombia • Aim: Symptom relief
Last updated Jun 27, 2026 12:39 UTC
-
Stomach cancer surgery may get simpler: omentum preservation under study
Disease control Recruiting nowCurative therapy for gastric cancer usually consists of perioperative chemotherapy and a radical (R0) gastrectomy. A radical resection includes a modified D2 lymphadenectomy, and, generally, a complete omentectomy, to ensure the removal of omental metastatic lymph nodes and tumor…
Phase: NA • Sponsor: Amsterdam UMC • Aim: Disease control
Last updated Jun 26, 2026 14:22 UTC
-
Spotting psychosis early could change lives — a major study tests whether faster treatment leads to better recovery
Knowledge-focused Recruiting nowThis study examines whether an early-detection program for psychosis can shorten the time patients remain untreated after the first appearance of psychotic symptoms, and whether such a reduction improves later functioning for people with first-episode schizophrenia. Psychosis in…
Sponsor: Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital • Aim: Knowledge-focused
Last updated Jul 23, 2026 00:00 UTC
-
Could two radiation sessions be as good as five for prostate cancer?
Symptom relief Recruiting nowProstate Stereotactic ablative body radiotherapy (SABR) is an established technique that delivers radiation in a non-invasive approach for men with prostate cancer. The treatment regimen is given in total of 5 fractions with one treatment per day at every other day or weekly sess…
Phase: NA • Sponsor: Sunnybrook Health Sciences Centre • Aim: Symptom relief
Last updated Jun 26, 2026 14:32 UTC
-
Bone drug boosts sperm in infertile men?
Disease control CompletedThis randomized controlled trial aims to assess whether treatment with denosumab can improve semen quality in infertile men selected by serum anti-mullerian hormone (AMH) as a positive predictive biomarker, and with severely impaired semen quality (concentrations between 0.01 mil…
Phase: PHASE1, PHASE2 • Sponsor: Martin Blomberg Jensen • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Can shedding pounds add years? new study compares diets, drugs, and surgery
Disease control Recruiting nowBackground. The prevalence of type 2 diabetes mellitus (T2D) in the world is constantly increasing. Treatment of T2D is complicated by arterial hypertension and obesity (metabolic syndrome - MS). Cardiovascular complications are the main cause of death in patients with MS. Object…
Phase: PHASE4 • Sponsor: University Medical Center, Kazakhstan • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Experimental t cell therapy targets Hard-to-Treat KRAS cancers
Disease control Recruiting nowAt present, there is an urgent need for new drugs for KRAS mutant tumors in clinic. Preclinical studies support the specificity, safety and anti-tumor activity of RE002. Previous similar studies suggest the feasibility of TCR-T treatment, and measures have been taken to ensure th…
Phase: PHASE1 • Sponsor: Henan Cancer Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Timing is everything: new study tests if stem cell infusion time prevents transplant complications
Knowledge-focused OngoingTo observe the effect of stem cell infusion on the development of acute graft-versus-host disease (aGVHD) in patients with malignant hematologic diseases after allogeneic peripheral blood hematopoietic stem cell transplantation (allo-PBSCT)
Phase: PHASE3 • Sponsor: Anhui Provincial Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:07 UTC
-
Could a plasma injection prevent colon Re-Narrowing in Crohn's?
Disease control ENROLLING_BY_INVITATIONThe aim was to investigate whether endoscopic balloon dilatation combined with PRP injection can help prevent or prolong restenosis in patients with Crohn's disease with colonic stenosis, and to explore the concentration of PRP. The study was a single-center, randomized, non-cont…
Phase: NA • Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC